en
Scientific article
Open access
English

Tyrosine kinase drug discovery: what can be learned from solved crystal structures?

Published inARKIVOC, no. 8, p. 38-49
Publication date2006
Abstract

Understanding molecular recognition during ligand binding is crucial for rational drug design. Protein kinases are a well known pharmacological target, especially in the therapeutic area of cancer. Solved crystal structures of tyrosine kinase domains in complex with ligands deliver insight into the binding event. These experimental data were collected and analysed by means of molecular modelling techniques. Common molecular recognition patterns were depicted and studied among this class of proteins. The results of this analysis and the consequences for rational design of inhibitors are presented.

Keywords
  • Tyrosine kinase ligands
  • Molecular modelling
  • Ligand core
  • Inhibitor minimal requirements and conserved ligand-kinase interactions
Citation (ISO format)
MORETTI, Loris, TCHERNIN, Laura, SCAPOZZA, Leonardo. Tyrosine kinase drug discovery: what can be learned from solved crystal structures? In: ARKIVOC, 2006, n° 8, p. 38–49. doi: 10.3998/ark.5550190.0007.805
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal1551-7004
477views
369downloads

Technical informations

Creation2016/01/27 11:58:00
First validation2016/01/27 11:58:00
Update time2023/03/15 00:07:24
Status update2023/03/15 00:07:24
Last indexation2024/01/16 20:11:08
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack